222 related articles for article (PubMed ID: 11020449)
1. Inhibition by diallyl trisulfide, a garlic component, of intracellular Ca(2+) mobilization without affecting inositol-1,4, 5-trisphosphate (IP(3)) formation in activated platelets.
Qi R; Liao F; Inoue K; Yatomi Y; Sato K; Ozaki Y
Biochem Pharmacol; 2000 Nov; 60(10):1475-83. PubMed ID: 11020449
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner.
Cho HJ; Cho JY; Rhee MH; Park HJ
Eur J Pharmacol; 2007 Mar; 558(1-3):43-51. PubMed ID: 17229422
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
[TBL] [Abstract][Full Text] [Related]
6. Diallyl Trisulfide Inhibits Platelet Aggregation through the Modification of Sulfhydryl Groups.
Hosono T; Sato A; Nakaguchi N; Ozaki-Masuzawa Y; Seki T
J Agric Food Chem; 2020 Feb; 68(6):1571-1578. PubMed ID: 31927886
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-3,4,5-trisphosphate stimulates Ca(2+) elevation and Akt phosphorylation to constitute a major mechanism of thromboxane A2 formation in human platelets.
Kassouf N; Ambily A; Watson S; Hassock S; Authi HS; Srivastava S; Watson SP; Authi KS
Cell Signal; 2015 Jul; 27(7):1488-98. PubMed ID: 25797048
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
10. Melatonin elevates intracellular free calcium in human platelets by inositol 1,4,5-trisphosphate independent mechanism.
Kumari S; Dash D
FEBS Lett; 2011 Jul; 585(14):2345-51. PubMed ID: 21664910
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
12. HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate.
Nofer JR; Walter M; Kehrel B; Wierwille S; Tepel M; Seedorf U; Assmann G
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):861-9. PubMed ID: 9633924
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin-permeabilized platelets.
Knezevic I; Dieter JP; Le Breton GC
J Pharmacol Exp Ther; 1992 Mar; 260(3):947-55. PubMed ID: 1545407
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a role for tyrosine phosphorylation of phospholipase C gamma 2 in collagen-induced platelet cytosolic calcium mobilization.
Daniel JL; Dangelmaier C; Smith JB
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):617-22. PubMed ID: 8093016
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
Endale M; Lee WM; Kamruzzaman SM; Kim SD; Park JY; Park MH; Park TY; Park HJ; Cho JY; Rhee MH
Br J Pharmacol; 2012 Sep; 167(1):109-27. PubMed ID: 22471932
[TBL] [Abstract][Full Text] [Related]
17. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
[TBL] [Abstract][Full Text] [Related]
19. Functional role of the calmodulin- and inositol 1,4,5-trisphosphate receptor-binding (CIRB) site of TRPC6 in human platelet activation.
Dionisio N; Albarran L; Berna-Erro A; Hernandez-Cruz JM; Salido GM; Rosado JA
Cell Signal; 2011 Nov; 23(11):1850-6. PubMed ID: 21757000
[TBL] [Abstract][Full Text] [Related]
20. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
